Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

OGEN 2.5

ESTROPIPATE

Standard Dose
3MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview OGEN 2.5 is listed in Drugs@FDA under application 083220 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient ESTROPIPATE Form and strength TABLET;ORAL - 3MG Sponsor PFIZER Submission history Latest submission status date: 2024-02-15 00:00:00.

Structured Monograph

Clinical summary

Approval overview OGEN 2.5 is listed in Drugs@FDA under application 083220 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ESTROPIPATE Form and strength TABLET;ORAL - 3MG Sponsor PFIZER Submission history Latest submission status date: 2024-02-15 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.